Mahdi Saghari

OX40L Inhibition Suppresses KLH‐driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof‐of‐Pharmacology for KY1005

Mahdi Saghari, Pim Gal, Sally Gilbert et al. · Clinical Pharmacology & Therapeutics · 2022 · 44 citations · Full text

First Clinical Study with AP30663 ‐ a K_Ca2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation

Pim Gal, Erica S. Klaassen, Kirsten R. Bergmann et al. · Clinical and Translational Science · 2020 · 34 citations · Full text

Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition

Jannik Rousel, Andreea Nădăban, Mahdi Saghari et al. · Experimental Dermatology · 2023 · 27 citations · Full text

Inflammation, Ophthalmology, Lesional Skin +15

Clinical application of oral form of ANGIPARS™ and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial

D Beyki, Mahdi Eftekhari, B Falahi et al. · DARU Journal of Pharmaceutical Sciences · 2008 · 24 citations

Diabetic Foot Ulcers, Diabetes, Lower Extremity Wound +6

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

Aliede E. in ‘t Veld, Hendrika W. Grievink, Mahdi Saghari et al. · International Journal of Molecular Sciences · 2019 · 16 citations · Full text